Plain-English translation of NCT05678062 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Eclampsia is a serious pregnancy condition where dangerously high blood pressure causes seizures. This study uses ultrasound scans to examine how eclampsia affects the heart and lungs. Researchers want to understand these changes better so doctors can provide safer care during delivery.
Eclampsia can damage the heart, lungs, and brain, but doctors don't have good tools to quickly spot these injuries. This research aims to see if ultrasound scans can detect these problems early, which could help doctors choose the safest delivery method for each patient.
If you join this study, you will have two ultrasound examinations—one shortly after your initial medical care, and a second one 72–96 hours later. Each ultrasound takes about 35–40 minutes and checks your heart, lungs, and the area around your optic nerve. These scans happen alongside your regular pregnancy and delivery care and do not delay any urgent treatment you need.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
South Africa
Collaborators
Stanford University
Enrollment target
~70 participants
Started
November 2022
Primary completion
December 2024
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Robert Dyer, MBChB, PhD
University of Cape Town